QQQ   352.01 (+1.16%)
AAPL   180.09 (+1.60%)
MSFT   332.58 (+1.28%)
META   272.61 (+2.98%)
GOOGL   123.72 (+0.69%)
AMZN   122.77 (+1.82%)
TSLA   207.52 (+1.76%)
NVDA   397.70 (+5.12%)
NIO   7.54 (+0.13%)
BABA   82.99 (+4.32%)
AMD   119.47 (+1.07%)
T   15.82 (+0.51%)
F   12.11 (+0.92%)
MU   69.09 (+1.30%)
CGC   0.83 (+0.00%)
GE   104.66 (+3.08%)
DIS   88.59 (+0.72%)
AMC   4.55 (+0.89%)
PFE   38.04 (+0.03%)
PYPL   63.05 (+1.71%)
NFLX   403.13 (+2.00%)
QQQ   352.01 (+1.16%)
AAPL   180.09 (+1.60%)
MSFT   332.58 (+1.28%)
META   272.61 (+2.98%)
GOOGL   123.72 (+0.69%)
AMZN   122.77 (+1.82%)
TSLA   207.52 (+1.76%)
NVDA   397.70 (+5.12%)
NIO   7.54 (+0.13%)
BABA   82.99 (+4.32%)
AMD   119.47 (+1.07%)
T   15.82 (+0.51%)
F   12.11 (+0.92%)
MU   69.09 (+1.30%)
CGC   0.83 (+0.00%)
GE   104.66 (+3.08%)
DIS   88.59 (+0.72%)
AMC   4.55 (+0.89%)
PFE   38.04 (+0.03%)
PYPL   63.05 (+1.71%)
NFLX   403.13 (+2.00%)
QQQ   352.01 (+1.16%)
AAPL   180.09 (+1.60%)
MSFT   332.58 (+1.28%)
META   272.61 (+2.98%)
GOOGL   123.72 (+0.69%)
AMZN   122.77 (+1.82%)
TSLA   207.52 (+1.76%)
NVDA   397.70 (+5.12%)
NIO   7.54 (+0.13%)
BABA   82.99 (+4.32%)
AMD   119.47 (+1.07%)
T   15.82 (+0.51%)
F   12.11 (+0.92%)
MU   69.09 (+1.30%)
CGC   0.83 (+0.00%)
GE   104.66 (+3.08%)
DIS   88.59 (+0.72%)
AMC   4.55 (+0.89%)
PFE   38.04 (+0.03%)
PYPL   63.05 (+1.71%)
NFLX   403.13 (+2.00%)
QQQ   352.01 (+1.16%)
AAPL   180.09 (+1.60%)
MSFT   332.58 (+1.28%)
META   272.61 (+2.98%)
GOOGL   123.72 (+0.69%)
AMZN   122.77 (+1.82%)
TSLA   207.52 (+1.76%)
NVDA   397.70 (+5.12%)
NIO   7.54 (+0.13%)
BABA   82.99 (+4.32%)
AMD   119.47 (+1.07%)
T   15.82 (+0.51%)
F   12.11 (+0.92%)
MU   69.09 (+1.30%)
CGC   0.83 (+0.00%)
GE   104.66 (+3.08%)
DIS   88.59 (+0.72%)
AMC   4.55 (+0.89%)
PFE   38.04 (+0.03%)
PYPL   63.05 (+1.71%)
NFLX   403.13 (+2.00%)
NASDAQ:CRSP

CRISPR Therapeutics (CRSP) News Today

$64.52
+0.48 (+0.75%)
(As of 06/1/2023 ET)
Compare
Today's Range
$62.84
▼
$65.60
50-Day Range
$43.43
▼
$67.77
52-Week Range
$38.94
▼
$86.95
Volume
1.26 million shs
Average Volume
1.23 million shs
Market Capitalization
$5.09 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$74.89
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media
Get CRISPR Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for CRSP and its competitors with MarketBeat's FREE daily newsletter.



CRSP Media Mentions By Week

CRSP Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CRSP
News Sentiment
▼
0.97

0.47
▲
Average
Medical
News Sentiment

CRSP News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CRSP Articles
This Week
▼
21

5
▲
CRSP Articles
Average Week

SourceHeadline
msn.com logoBarclays Maintains CRISPR Therapeutics (CRSP) Equal-Weight Recommendation
msn.com - June 1 at 1:34 PM
MarketBeat logoBarclays Increases CRISPR Therapeutics (NASDAQ:CRSP) Price Target to $64.00
americanbankingnews.com - June 1 at 8:48 AM
markets.businessinsider.com logoAnalysts Conflicted on These Healthcare Names: Phreesia (PHR), Crispr Therapeutics AG (CRSP) and Ascendis Pharma (ASND)
markets.businessinsider.com - June 1 at 8:33 AM
MarketBeat logoQ2 2023 Earnings Estimate for CRISPR Therapeutics AG (NASDAQ:CRSP) Issued By William Blair
americanbankingnews.com - June 1 at 8:10 AM
MarketBeat logoCRISPR Therapeutics AG (NASDAQ:CRSP) Sees Significant Decline in Short Interest
americanbankingnews.com - June 1 at 7:22 AM
marketbeat.com logoFranklin Resources Inc. Decreases Stock Position in CRISPR Therapeutics AG (NASDAQ:CRSP)
marketbeat.com - June 1 at 6:43 AM
MarketBeat logoWilliam Blair Begins Coverage on CRISPR Therapeutics (NASDAQ:CRSP)
americanbankingnews.com - June 1 at 2:58 AM
MarketBeat logoCRISPR Therapeutics AG Forecasted to Post Q1 2024 Earnings of ($2.18) Per Share (NASDAQ:CRSP)
americanbankingnews.com - May 31 at 7:24 AM
marketbeat.com logoRaymond James & Associates Boosts Stake in CRISPR Therapeutics AG (NASDAQ:CRSP)
marketbeat.com - May 31 at 4:58 AM
msn.com logoWilliam Blair Reiterates CRISPR Therapeutics (CRSP) Outperform Recommendation
msn.com - May 30 at 7:04 PM
finance.yahoo.com logoCRISPR Therapeutics (NASDAQ:CRSP) shareholders are still up 11% over 1 year despite pulling back 3.8% in the past week
finance.yahoo.com - May 30 at 2:03 PM
marketbeat.com logoHighTower Advisors LLC Has $1.23 Million Stock Holdings in CRISPR Therapeutics AG (NASDAQ:CRSP)
marketbeat.com - May 28 at 4:57 AM
marketbeat.com logoCRISPR Therapeutics AG (NASDAQ:CRSP) Shares Acquired by CI Investments Inc.
marketbeat.com - May 26 at 6:33 AM
benzinga.com logoCRISPR Therapeutics Stock (NASDAQ:CRSP), Short Interest Report
benzinga.com - May 25 at 7:15 PM
MarketBeat logoQ2 2023 Earnings Forecast for CRISPR Therapeutics AG (NASDAQ:CRSP) Issued By Zacks Research
americanbankingnews.com - May 25 at 6:23 AM
MarketBeat logoCRISPR Therapeutics (NASDAQ:CRSP) Trading Up 6.8% Following Analyst Upgrade
americanbankingnews.com - May 25 at 1:18 AM
marketbeat.com logoCRISPR Therapeutics AG (NASDAQ:CRSP) Shares Sold by FDx Advisors Inc.
marketbeat.com - May 24 at 6:20 AM
msn.com logoCitigroup Maintains CRISPR Therapeutics (CRSP) Neutral Recommendation
msn.com - May 24 at 12:14 AM
benzinga.com logoCRISPR Therapeutics Unusual Options Activity
benzinga.com - May 23 at 7:14 PM
msn.com logoCRISPR Therapeutics Earnings Perspective: Return On Capital Employed
msn.com - May 23 at 2:13 PM
finance.yahoo.com logoCRISPR Therapeutics Stock Joins Rank Of Stocks With RS Ratings Over 90
finance.yahoo.com - May 23 at 2:13 PM
marketbeat.com logoNEA Management Company LLC Has $64.55 Million Holdings in CRISPR Therapeutics AG (NASDAQ:CRSP)
marketbeat.com - May 23 at 1:04 PM
MarketBeat logoCRISPR Therapeutics (NASDAQ:CRSP) Price Target Raised to $70.00 at Citigroup
americanbankingnews.com - May 23 at 8:05 AM
seekingalpha.com logoCrispr Therapeutics: Hold Until A Firmer Decision Date
seekingalpha.com - May 19 at 10:32 AM
marketbeat.com logoCalifornia Public Employees Retirement System Sells 12,783 Shares of CRISPR Therapeutics AG (NASDAQ:CRSP)
marketbeat.com - May 19 at 5:19 AM
marketbeat.com logoVertex Pharmaceuticals Hits Record High on Strong Q1 Earnings (CRSP)
marketbeat.com - May 18 at 8:35 AM
MarketBeat logoCRISPR Therapeutics (NASDAQ:CRSP) Trading Down 5.3%
americanbankingnews.com - May 18 at 7:18 AM
MarketBeat logoCRISPR Therapeutics (NASDAQ:CRSP) Trading Up 5.3%
americanbankingnews.com - May 17 at 8:02 AM
marketbeat.com logoCommonwealth Equity Services LLC Has $2.08 Million Stock Position in CRISPR Therapeutics AG (NASDAQ:CRSP)
marketbeat.com - May 17 at 5:12 AM
markets.businessinsider.com logoStifel Nicolaus Remains a Hold on Crispr Therapeutics AG (CRSP)
markets.businessinsider.com - May 16 at 10:25 PM
marketbeat.com logoBedell Frazier Investment Counseling LLC Lowers Stock Holdings in CRISPR Therapeutics AG (NASDAQ:CRSP)
marketbeat.com - May 16 at 12:34 PM
MarketBeat logoCantor Fitzgerald Weighs in on CRISPR Therapeutics AG's FY2023 Earnings (NASDAQ:CRSP)
americanbankingnews.com - May 16 at 3:54 AM
realmoney.thestreet.com logoWhy Are CRISPR Therapeutics Charts Saying 'Buy'?
realmoney.thestreet.com - May 16 at 3:40 AM
seekingalpha.com logoCRISPR Therapeutics AG (CRSP) JMP Securities Life Sciences Conference (Transcript)
seekingalpha.com - May 15 at 1:48 PM
seekingalpha.com logoCRISPR Therapeutics AG (CRSP) Presents at JMP Securities Life Sciences Conference (Transcript)
seekingalpha.com - May 15 at 1:48 PM
marketbeat.com logoCRISPR Therapeutics AG (NASDAQ:CRSP) to Post FY2023 Earnings of ($8.17) Per Share, Cantor Fitzgerald Forecasts
marketbeat.com - May 15 at 3:44 AM
MarketBeat logoCRISPR Therapeutics (NASDAQ:CRSP) Upgraded at StockNews.com
americanbankingnews.com - May 14 at 5:36 AM
MarketBeat logoChardan Capital Analysts Decrease Earnings Estimates for CRISPR Therapeutics AG (NASDAQ:CRSP)
americanbankingnews.com - May 14 at 3:20 AM
seekingalpha.com logoCRISPR Therapeutics AG (CRSP) Presents at Bank of America Securities 2023 Health Care Conference (Transcript)
seekingalpha.com - May 13 at 7:08 PM
seekingalpha.com logoCRISPR Therapeutics AG (CRSP) Presents at Bank of America Securities 2023 Health Care Conference (Transcript)
seekingalpha.com - May 13 at 7:08 PM
MarketBeat logoQ2 2023 Earnings Estimate for CRISPR Therapeutics AG Issued By Brookline Capital Management (NASDAQ:CRSP)
americanbankingnews.com - May 13 at 3:22 AM
MarketBeat logoCRISPR Therapeutics' (CRSP) "Reiterates" Rating Reaffirmed at VNET Group
americanbankingnews.com - May 13 at 1:38 AM
msn.com logoMorgan Stanley Maintains CRISPR Therapeutics (CRSP) Underweight Recommendation
msn.com - May 12 at 3:54 PM
marketbeat.com logoChardan Capital Analysts Reduce Earnings Estimates for CRISPR Therapeutics AG (NASDAQ:CRSP)
marketbeat.com - May 12 at 9:40 AM
marketbeat.com logoNordea Investment Management AB Has $4.05 Million Stock Position in CRISPR Therapeutics AG (NASDAQ:CRSP)
marketbeat.com - May 12 at 5:49 AM
MarketBeat logoEquities Analysts Set Expectations for CRISPR Therapeutics AG's FY2024 Earnings (NASDAQ:CRSP)
americanbankingnews.com - May 12 at 5:04 AM
marketbeat.com logoVan ECK Associates Corp Acquires 14,084 Shares of CRISPR Therapeutics AG (NASDAQ:CRSP)
marketbeat.com - May 11 at 6:33 AM
MarketBeat logoCRISPR Therapeutics AG (NASDAQ:CRSP) Receives $72.84 Average PT from Brokerages
americanbankingnews.com - May 11 at 2:38 AM
markets.businessinsider.com logoRBC Capital Keeps Their Hold Rating on Crispr Therapeutics AG (CRSP)
markets.businessinsider.com - May 10 at 6:03 PM
benzinga.com logoThis Is What Whales Are Betting On CRISPR Therapeutics
benzinga.com - May 10 at 6:03 PM
Get CRISPR Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for CRSP and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NASDAQ:CRSP) was last updated on 6/1/2023 by MarketBeat.com Staff

My Account -